NCT01343914View on ClinicalTrials.gov

An Observational Study on Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin (Bevacizumab)-Based First-Line Therapy

CompletedOBSERVATIONAL

Enrollment

118

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Non-Squamous Non-Small Cell Lung Cancer

Trial Locations (33)

3010

Alicante

10003

Cáceres

15706

Santiago de Compostela

23007

Jaén

24071

León

27004

Lugo

28007

Madrid

28033

Madrid

28034

Madrid

28040

Madrid

28046

Madrid

28050

Madrid

28702

San Sebastián de los Reyes

28935

Madrid

29010

Málaga

30008

Murcia

31008

Navarra

36002

Pontevedra

36312

Vigo

41013

Seville

46015

Valencia

46017

Valencia

46026

Valencia

50009

Zaragoza

03804

Alcoy

03203

Elche

03600

Elda

04009

Almería

07500

Manacor

07012

Palma de Mallorca

08028

Barcelona

08041

Barcelona

08916

Barcelona

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT01343914 - An Observational Study on Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin (Bevacizumab)-Based First-Line Therapy | Biotech Hunter | Biotech Hunter